The complement cascade: Yin–Yang in neuroinflammation – neuro‐protection and ‐degeneration

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Neurochemistry

• Publication date

  2008-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1471-4159.2008.05668.xPMID 18786171PMCID PMC4038542
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Central Nervous System Diseases and Inflammation

  2008cited by this paper
• Complement C3 Deficiency Leads to Accelerated Amyloid β Plaque Deposition and Neurodegeneration and Modulation of the Microglia/Macrophage Phenotype in Amyloid Precursor Protein Transgenic Mice

  2008cited by this paper
• Interleukin (IL)-6 and IL-1 beta act synergistically within the brain to induce sickness behavior and fever in rats.

  2008cited by this paper
• A Transcriptome Database for Astrocytes, Neurons, and Oligodendrocytes: A New Resource for Understanding Brain Development and Function

  2008cited by this paper
• TUESDAY SESSION

  2008cited by this paper
• Characterization of early and terminal complement proteins associated with polymorphonuclear leukocytes in vitro and in vivo after spinal cord injury

  2008cited by this paper
• Deficiency in Complement C1q Improves Histological and Functional Locomotor Outcome after Spinal Cord Injury

  2008cited by this paper
• Complement C3 and C4 expression in C1q sufficient and deficient mouse models of Alzheimer’s disease

  2008cited by this paper
• Plaque complement activation and cognitive loss in Alzheimer's disease

  2008cited by this paper
• Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s disease

  2008cited by this paper
• Role of complement and complement regulators in the removal of apoptotic cells.

  2008cited by this paper
• Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury.

  2008cited by this paper
• Low-Dose Targeted Complement Inhibition Protects against Renal Disease and Other Manifestations of Autoimmune Disease in MRL/lpr Mice1

  2008cited by this paper
• Complement anaphylatoxin C5a neuroprotects through regulation of glutamate receptor subunit 2 in vitro and in vivo

  2008cited by this paper
• The Membrane Attack Complex of the Complement System Is Essential for Rapid Wallerian Degeneration

  2007cited by this paper
• Polymorphonuclear leukocytes promote neurotoxicity through release of matrix metalloproteinases, reactive oxygen species, and TNF‐α

  2007cited by this paper
• Myelin—Associated Inhibitory Signaling and Strategies to Overcome Inhibition

  2007cited by this paper
• New therapeutic approaches for multiple sclerosis.

  2007cited by this paper
• Multiple sclerosis: a complicated picture of autoimmunity

  2007cited by this paper
• Disinhibition of neurite growth to repair the injured adult CNS: Focusing on Nogo

  2007cited by this paper
• Complement Induction in Spinal Cord Microglia Results in Anaphylatoxin C5a-Mediated Pain Hypersensitivity

  2007cited by this paper
• p150/95 (CD11c/CD18) expression is required for the development of experimental autoimmune encephalomyelitis.

  2007cited by this paper
• Systemic lupus erythematosus and the brain: what mice are telling us.

  2007cited by this paper
• The classical complement cascade mediates CNS synapse elimination.

  2007influential reference
• Complement component C1q inhibits β‐amyloid‐ and serum amyloid P‐induced neurotoxicity via caspase‐ and calpain‐independent mechanisms

  2007cited by this paper
• Absence of functional alternative complement pathway alleviates lupus cerebritis

  2007cited by this paper
• A novel inhibitor of the alternative pathway of complement reverses inflammation and bone destruction in experimental arthritis

  2007cited by this paper
• B cells: No longer the nondominant arm of multiple sclerosis

  2007cited by this paper
• Restoring function after spinal cord injury: promoting spontaneous regeneration with stem cells and activity-based therapies.

  2007cited by this paper
• Absence of glaucoma in DBA/2J mice homozygous for wild-type versions of Gpnmb and Tyrp1

  2007cited by this paper
• Complement proteins C1q and MBL are pattern recognition molecules that signal immediate and long-term protective immune functions.

  2007cited by this paper
• Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo.

  2007cited by this paper
• BMC Genetics BioMed Central

  2007cited by this paper
• Comparative immunopathogenesis of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis

  2007cited by this paper
• Complement-targeted therapeutics

  2007cited by this paper
• Distinct roles for spontaneous and visual activity in remodeling of the retinogeniculate synapse.

  2006cited by this paper
• C5b-9 complement complex in autoimmune demyelination: dual role in neuroinflammation and neuroprotection.

  2006influential reference
• The role of the complement system in CNS inflammatory diseases

  2006cited by this paper
• The cellular inflammatory response in human spinal cords after injury.

  2006cited by this paper
• Overcoming Inhibition in the Damaged Spinal Cord

  2006cited by this paper
• Comparative analysis of lesion development and intraspinal inflammation in four strains of mice following spinal contusion injury

  2006cited by this paper
• How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis

  2006cited by this paper
• Microarray analysis of retinal gene expression in the DBA/2J model of glaucoma.

  2006cited by this paper
• EAE: pitfalls outweigh virtues of screening potential treatments for multiple sclerosis.

  2006cited by this paper
• Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden

  2006cited by this paper
• Generation of C5a in the absence of C3: a new complement activation pathway

  2006cited by this paper
• Complement-Dependent P-Selectin Expression and Injury following Ischemic Stroke1

  2006cited by this paper
• Complement in BuB/BnJ mice revisited: serum C3 levels and complement opsonic activity are not elevated.

  2006influential reference
• Roles of immunoglobulins and B cells in multiple sclerosis: from pathogenesis to treatment.

  2006cited by this paper
• Complement component 1Q (C1Q) upregulation in retina of murine, primate, and human glaucomatous eyes.

  2006cited by this paper
• Complement plays an important role in spinal cord injury and represents a therapeutic target for improving recovery following trauma.

  2006cited by this paper
• C1q and MBL, components of the innate immune system, influence monocyte cytokine expression

  2006cited by this paper
• Complement and demyelinating disease: no MAC needed?

  2006cited by this paper
• Oligodendrocyte cell death in pathogenesis of multiple sclerosis: Protection of oligodendrocytes from apoptosis by complement.

  2006cited by this paper
• Complement: a novel factor in basal and ischemia‐induced neurogenesis

  2006cited by this paper
• IMMUNE MECHANISMS IN ATHEROSCLEROSIS Focus on the Role of the Complement System

  2006cited by this paper
• The complement system in central nervous system diseases

  2006cited by this paper
• Inflammatory-mediated injury and repair in the traumatically injured spinal cord.

  2005cited by this paper
• MRL/lpr mice have alterations in brain metabolism as shown with [1H-13C] NMR spectroscopy.

  2005cited by this paper
• Inherited glaucoma in DBA/2J mice: pertinent disease features for studying the neurodegeneration.

  2005cited by this paper
• C5b-9 Terminal Complex Protects Oligodendrocytes from Apoptotic Cell Death by Inhibiting Caspase-8 Processing and Up-Regulating FLIP1

  2005cited by this paper
• Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus

  2005cited by this paper
• Complement-Dependent Apoptosis and Inflammatory Gene Changes in Murine Lupus Cerebritis1

  2005cited by this paper
• Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective.

  2005cited by this paper
• Immunology of multiple sclerosis.

  2005cited by this paper
• Upregulation of Complement Inhibitors in Association with Vulnerable Cells following Contusion-Induced Spinal Cord Injury

  2005cited by this paper
• EncephalomyelitisExperimental Autoimmune Cells and Accessory Cells for Development of Critical Requirement of CD11b (Mac-1) on T

  2005cited by this paper
• Immune response to immunotherapy: the role of neutralising antibodies to interferon beta in the treatment of multiple sclerosis.

  2005cited by this paper
• The Pathology of Multiple Sclerosis Is Location-Dependent: No Significant Complement Activation Is Detected in Purely Cortical Lesions

  2005cited by this paper
• Murine complement C4 is not required for experimental autoimmune encephalomyelitis

  2005cited by this paper
• Basement Membrane Proteins in Multiple Sclerosis-Associated Inflammatory Cuffs: Potential Role in Influx and Transport of Leukocytes

  2005cited by this paper
• Reactive Astrocytes in Neural Repair and Protection

  2005cited by this paper
• Signaling between glia and neurons: focus on synaptic plasticity.

  2005cited by this paper
• C5b‐9 complement complex in autoimmune demyelination and multiple sclerosis: Dual role in neuroinflammation and neuroprotection

  2005cited by this paper
• Retinal ganglion cell degeneration is topological but not cell type specific in DBA/2J mice

  2005cited by this paper
• Novel biological networks modulated by complement.

  2005cited by this paper
• Complement Activation in Very Early Alzheimer Disease

  2005cited by this paper
• Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection.

  2005cited by this paper
• Activation of the spinal cord complement cascade might contribute to mechanical allodynia induced by three animal models of spinal sensitization.

  2005cited by this paper
• Expression of C5a in the brain does not exacerbate experimental autoimmune encephalomyelitis.

  2005influential reference
• ReviewTwenty Years of the Alzheimer ’ s Disease Amyloid Hypothesis : A Genetic Perspective

  2005cited by this paper
• Regeneration beyond the glial scar

  2004cited by this paper
• Deletion of the Complement Anaphylatoxin C3a Receptor Attenuates, Whereas Ectopic Expression of C3a in the Brain Exacerbates, Experimental Autoimmune Encephalomyelitis1

  2004cited by this paper
• Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion

  2004cited by this paper
• Reactive Astrocytes Protect Tissue and Preserve Function after Spinal Cord Injury

  2004cited by this paper
• Early complement activation increases in the brain in some aged normal subjects.

  2004cited by this paper
• Activation of Complement Pathways after Contusion-Induced Spinal Cord Injury

  2004cited by this paper
• A Regulatory Role for Complement in Innate Immunity and Autoimmunity

  2004cited by this paper
• Vaccinia Virus Complement Control Protein Reduces Inflammation and Improves Spinal Cord Integrity Following Spinal Cord Injury

  2004cited by this paper
• Microarray analysis of changes in mRNA levels in the rat retina after experimental elevation of intraocular pressure.

  2004cited by this paper
• Role for glia in synaptogenesis

  2004cited by this paper
• Incipient Alzheimer's disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses

  2004cited by this paper
• Peripheral Treatment with Enoxaparin, a Low Molecular Weight Heparin, Reduces Plaques and β-Amyloid Accumulation in a Mouse Model of Alzheimer's Disease

  2004cited by this paper
• New directions in MS therapeutics: vehicles of hope.

  2004cited by this paper
• Neural activity and the dynamics of central nervous system development

  2004cited by this paper
• Absence of C1q Leads to Less Neuropathology in Transgenic Mouse Models of Alzheimer's Disease

  2004cited by this paper
• Anti-macrophage CR3 antibody blocks myelin phagocytosis by macrophages in vitro

  2004cited by this paper
• The Proinflammatory Mediators C3a and C5a Are Essential for Liver Regeneration

  2003cited by this paper
• Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis

  2003cited by this paper
• Yin and Yang: complement activation and regulation in Alzheimer's disease.

  2003influential reference

• Central nervous system-penetrant anti-C1q therapy reduces neuroinflammation and preserves neurological function in a model of progressive multiple sclerosis.

  2026cites this paper
• Complement at the Nano–Neuroimmune Interface: A Hypothesis-Driven Perspective on Opioid Use Disorder

  2026cites this paper
• Complement pathway dysregulation and astrocyte alterations in Down syndrome: evidence from postmortem brain tissue and iPSC-derived astrocytes

  2025cites this paper
• Development of a High-throughput Morphological Assay for Evaluating Mesenchymal Stromal Cell-derived Extracellular Vesicle Modulation of Brain Pericyte Secretory Phenotype

  2025cites this paper
• Transcriptomic Signatures of Neuroinflammation and Adaptive Immunity in the Human SCG During Cardiac Disease: A Bulk RNA-seq Reanalysis

  2025influential citation
• Non-canonical Roles of Complement in the CNS: From Synaptic Organizer to Presynaptic Modulator of Glutamate Transmission

  2025cites this paper
• Decoding inflammatory pathways in spinal muscular atrophy: implications for next-generation therapies.

  2025cites this paper
• The Role of the Complement System in Synaptic Pruning after Stroke

  2024cites this paper
• Genetic factors associated with age-related macular degeneration modulating plasma inflammatory biomarker levels in patients with AIDS

  2024cites this paper
• Lipopolysaccharide exacerbates depressive‐like behaviors in obese rats through complement C1q‐mediated synaptic elimination by microglia

  2024cites this paper
• Glaucoma: from pathogenic mechanisms to retinal glial cell response to damage

  2024cites this paper
• The complement system: a potential target for the comorbidity of chronic pain and depression

  2024cites this paper
• Synapse Regulation.

  2024cites this paper
• Microglial Drivers of Alzheimer's Disease Pathology: An Evolution of Diverse Participating States

  2024cites this paper
• Complement C3a Receptor Antagonist Alleviates Tau Pathology and Ameliorates Cognitive Deficits in P301S Mice.

  2023cites this paper
• Brain Expression of CPB2 and Effects of Cpb2 Deficiency in Mouse Models of Behavior

  2023cites this paper
• Complement: The Road Less Traveled.

  2023cites this paper
• The case for complement component 5 as a target in neurodegenerative disease

  2023cites this paper
• Update on Central Nervous System Effects of HIV in Adolescents and Young Adults

  2023cites this paper
• The association between serum complement C3a and severity in patients with community-acquired pneumonia

  2023cites this paper
• Ependyma in Neurodegenerative Diseases, Radiation-Induced Brain Injury and as a Therapeutic Target for Neurotrophic Factors

  2023cites this paper
• Microglia in motor neuron disease: Signaling evidence from last 10 years

  2022cites this paper
• Divergent complement system activation in two clinically distinct murine models of multiple sclerosis

  2022cites this paper
• Administration of C5a Receptor Antagonist Improves the Efficacy of Human Induced Pluripotent Stem Cell–Derived Neural Stem/Progenitor Cell Transplantation in the Acute Phase of Spinal Cord Injury

  2022cites this paper
• Nanoparticles for the treatment of glaucoma-associated neuroinflammation

  2022cites this paper
• Classical complement pathway factor alterations in narcolepsy.

  2022cites this paper
• Identification of Molecular Correlations Between DHRS4 and Progressive Neurodegeneration in Amyotrophic Lateral Sclerosis By Gene Co-Expression Network Analysis

  2022cites this paper
• Complement and Coagulation System Crosstalk in Synaptic and Neural Conduction in the Central and Peripheral Nervous Systems

  2021cites this paper
• miR-142 downregulation alleviates rat PTSD-like behaviors, reduces the level of inflammatory cytokine expression and apoptosis in hippocampus, and upregulates the expression of fragile X mental retardation protein

  2021cites this paper
• Antibodies Against the NH2-Terminus of the GluA Subunits Affect the AMPA-Evoked Releasing Activity: The Role of Complement

  2021cites this paper
• DTI and MTR Measures of Nerve Fiber Integrity in Pediatric Patients With Ankle Injury

  2021cites this paper
• MERS-CoV infection causes brain damage in human DPP4-transgenic mice through complement-mediated inflammation

  2021cites this paper
• Extensive characterization of the composition and functional activities of five preparations of human platelet lysates for dedicated clinical uses

  2020cites this paper
• Complement C6 deficiency exacerbates pathophysiology after spinal cord injury

  2020cites this paper
• Complement in neurological disorders and emerging complement-targeted therapeutics

  2020cites this paper
• Neuroimmune crosstalk and evolving pharmacotherapies in neurodegenerative diseases

  2020cites this paper
• Ultra-High-Dose-Rate FLASH Irradiation Limits Reactive Gliosis in the Brain

  2020cites this paper
• Similarities between the Yin/Yang Doctrine and Hormesis in Toxicology and Pharmacology

  2020cites this paper
• A “Yin”-“Yang” complementarity strategy for design and fabrication of dual-responsive bimorph actuators

  2020cites this paper
• Complement: Bridging the innate and adaptive immune systems in sterile inflammation

  2020cites this paper
• Administration of C5a Receptor Antagonist Improves the E�cacy of Human iPSCS-derived NS/PC Transplantation in the Acute Phase Of spinal Cord Injury

  2020cites this paper
• Integrative brain transcriptome analysis links complement component 4 and HSPA2 to the APOE ε2 protective effect in Alzheimer disease

  2020cites this paper
• Microglia dynamics in adolescent traumatic brain injury

  2020cites this paper
• Microglial cell hyper-ramification and neuronal dendritic spine loss in the hippocampus and medial prefrontal cortex in a mouse model of PTSD.

  2019cites this paper
• Persistent Toxoplasma Infection of the Brain Induced Neurodegeneration Associated with Activation of Complement and Microglia

  2019cites this paper
• Complement and coagulation cascades in trauma

  2019cites this paper
• The Novel C5aR Antagonist DF3016A Protects Neurons Against Ischemic Neuroinflammatory Injury

  2019cites this paper
• Peripheral Markers of Immune Response in Major Psychiatric Disorders: Where Are We Now and Where Do We Want to Be?

  2019cites this paper
• Modulation of Iberian Ribbed Newt Complement Component C3 by Stressors Similar to those Encountered during a Stay Onboard the International Space Station

  2019cites this paper
• Mutant SOD1 prevents normal functional recovery through enhanced glial activation and loss of motor neuron innervation after peripheral nerve injury.

  2019cites this paper
• Adolescent microglia play a role in executive function in male mice exposed to perinatal high fat diet.

  2019cites this paper
• Role of Complement in Cerebral Malaria

  2018cites this paper
• Pharmaceutical Machine Learning: Virtual High-Throughput Screens Identifying Promising and Economical Small Molecule Inhibitors of Complement Factor C1s

  2018cites this paper
• Safety and Feasibility of Lin- Cells Administration to ALS Patients: A Novel View on Humoral Factors and miRNA Profiles

  2018cites this paper
• Towards a better understanding of the cannabinoid-related orphan receptors GPR3, GPR6, and GPR12

  2018cites this paper
• High-fructose diet during adolescent development increases neuroinflammation and depressive-like behavior without exacerbating outcomes after stroke.

  2018cites this paper
• Therapeutic modulation of Alzheimer’s disease with biological (HUCBS) and pharmacological (LISPRO) approaches

  2018cites this paper
• Orphan G protein-coupled receptors: The role in CNS disorders.

  2018cites this paper
• Human Cord Blood Serum-Derived APP α-Secretase Cleavage Activity is Mediated by C1 Complement

  2018cites this paper
• GPR3, GPR6, and GPR12 as novel molecular targets: their biological functions and interaction with cannabidiol

  2018cites this paper
• Complement Activation in Malaria Immunity and Pathogenesis

  2018cites this paper
• Assessment of Complement Cascade Components in Patients With Bipolar Disorder

  2018cites this paper
• Contribution of Neurons and Glial Cells to Complement-Mediated Synapse Removal during Development, Aging and in Alzheimer's Disease

  2018cites this paper
• A study of GPR3, GPR6, of GPR12 as novel molecular targets for cannabidiol.

  2018cites this paper
• Natural IgM antibodies that bind neoepitopes exposed as a result of spinal cord injury , drive secondary injury by activating complement

  2017cites this paper
• Cell-specific deletion of C1qa identifies microglia as the dominant source of C1q in mouse brain

  2017cites this paper
• Activation of anti-oxidant Nrf2 signaling by substituted trans stilbenes.

  2017cites this paper
• Association of complement receptor 1 gene polymorphisms with cognitive function

  2017cites this paper
• Mechanisms of action of intravenous immunoglobulin in septic encephalopathy

  2017cites this paper
• C5a Increases the Injury to Primary Neurons Elicited by Fibrillar Amyloid Beta

  2017cites this paper
• Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia.

  2017cites this paper
• Chapter 46 – Postinfectious Epilepsy

  2017cites this paper
• Immunomodulatory Role of Complement Proteins in the Neuropathology Associated with Opiate Abuse and HIV-1 Co-Morbidity

  2017cites this paper
• CIRCULATING AUTOANTIBODIES IN HUMAN TRAUMATIC SPINAL CORD INJURY SUBJECTS AND THEIR RELATIONSHIP TO THE DEVELOPMENT OF NEUROPATHIC PAIN

  2017cites this paper
• A model of the mitochondrial basis of bipolar disorder.

  2017cites this paper
• Roles of Pro- and Anti-inflammatory Cytokines in Traumatic Brain Injury and Acute Ischemic Stroke

  2017cites this paper
• Complement Protein C3 Suppresses Axon Growth and Promotes Neuron Loss

  2017cites this paper
• Complement Components Are Expressed by Infiltrating Macrophages/Activated Microglia Early Following Viral Infection

  2017cites this paper
• Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss

  2017cites this paper
• Association Analysis of Polymorphisms in TOMM40, CR1, PVRL2, SORL1, PICALM, and 14q32.13 Regions in Colombian Alzheimer Disease Patients

  2016cites this paper
• Association Between Microglia, Inflammatory Factors, and Complement with Loss of Hippocampal Mossy Fiber Synapses Induced by Trimethyltin

  2016cites this paper
• Rôle de la microglie dans la neurogenèse adulte, dans le bulbe olfactif de la souris

  2016cites this paper
• The complement system, neuronal injury, and cognitive function in horizontally-acquired HIV-infected youth

  2016cites this paper
• Inflammatory Products of the Complement Pathway

  2016cites this paper
• Intraneuronal Computation: Charting the Signaling Pathways of the Neuron

  2016cites this paper
• Complement system activation contributes to the ependymal damage induced by microbial neuraminidase

  2016cites this paper
• Complement Receptor 2 is increased in cerebrospinal fluid of multiple sclerosis patients and regulates C3 function.

  2016cites this paper
• Biocompatibility of neural electrodes or: Curbing the immune response against brain electrode implants

  2016cites this paper
• Inflammogenesis of Secondary Spinal Cord Injury

  2016cites this paper
• Title Analysis of the Putative Role of CR 1 in Alzheimer ' s Disease : Genetic Association , Expression and Function Permalink

  2016cites this paper
• Does C3-deficiency alter the amyloid precursor protein expression and thalamic structure following cranial radiotherapy to the developing brain?

  2016cites this paper
• When the Microenvironment Talks, Do Neural Stem Cells Listen? Novel Roles for Complement and Immune Interactions in Autocrine Regulation and Paracrine Modulation of Neural Stem Cells

  2016cites this paper
• Can microbiota research change our understanding of neurodegenerative diseases?

  2016cites this paper
• Analysis of the Putative Role of CR1 in Alzheimer’s Disease: Genetic Association, Expression and Function

  2016cites this paper
• Inhibition of complement C3 might rescue vascular hyporeactivity in a conscious hemorrhagic shock rat model.

  2016cites this paper
• Ischemic, traumatic and neurodegenerative brain inflammatory changes

  2016cites this paper
• High levels of serum mannose-binding lectins are associated with the severity and clinical outcomes of severe traumatic brain injury.

  2015cites this paper
• The Role of Inflammatory Mediators in the Pathogenesis of Alzheimer's Disease.

  2015cites this paper
• Role of complement in ALS: regulating peripheral immune cells in skeletal muscle of hSOD1G93A mouse model of ALS

  2015cites this paper
• Complement in the Homeostatic and Ischemic Brain

  2015cites this paper